baltimore conference logo
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Michael Sawyer, MD | Authors

Articles

Lean Body Mass as a Clinical Outcome in Multicentric Castleman’s Disease

September 03, 2014

Video

Michael Sawyer, MD, associate professor, Medical Oncology, University of Alberta, discusses lean body mass as a clinical outcome in multicentric Castleman’s disease.